References
- Chobanian AV, Bakris GL, Black HR, Cushman WC, et al. The seventh report of te Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289: 2560–2572
- Droyvold WB, Midthjell K, Nilsen TI, Holmen G. Change in body mass index and its impact on blood pressure: A prospective population study. Int J Obes. 2005; 29: 650–655
- Tsai P-S, Ke T-L, Huang C-J, Tsai JC, et al. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hyperten. 2006; 23: 1355–1360
- Papadopoulos DP, Makris TK, Krespi PG, Poulakou M, et al. Adiponectin and resistin plasma levels in healthy individuals with prehypertension. J Clin Hypertens. 2005; 7: 729–733
- Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among U.S. adults according to the new National Committee Guidelines. Arch Intern Med. 2004; 164: 2126–2134
- Sim MK, Qui XS. Angiotensins in plasma of hypertensive rats and human. Regul Pept. 2003; 111: 179–182
- Catena C, Zingaro L, Casaccio D, Sechi LA. Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance. Am J Med. 2000; 109: 556–561
- Cottone S, Mule G, Nardi E, Vadala A, et al. Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension. Am J Hypertens. 2006; 19: 313–318
- Kaibe M, Ohishi M, Ito N, Yuan M, et al. Serum interleukin-15 concentration in patients with essential hypertension. Am J Hypertens. 2005; 18: 1019–1025
- Jin X, Xia L, Wang LS, Zheng Y, et al. Differential protein expression in hypertrophic heart with and without hypertension in hypertaneously hypertensive rats. Proteomics. 2006; 6: 1948–1956
- Escobales N, Crespo MJ. Oxidative-nitrosative stress in hypertension. Curr Vasc Pharmacol. 2005; 3: 231–246
- Lee JE, Kim YG, Choi YH, et al. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension. 2006; 47: 962–967
- Liu N, Chen G, Wang X, Yao X, et al. Effects of certain vasoactive peptides on pathogenesis of vascular restenosis. Chin Med Sci J. 2003; 18: 1–8
- Zhou MS, Jaimes EA, Raij L. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress. J Hypertens. 2004; 44: 186–190
- Masley SC, Phillips SE, Schocken DD. Blood pressure as a predictor of cardiovascular events in the elderly: The William Hale Research Program. Hum Hypertens. 2006; 20: 392–397
- Lee JH, Hwang SY, Kim EJ, Kim MJ. Comparison of risk factors between prehypertension and hypertension in Korean male industrial workers. Public Health Nurs. 2006; 23: 314–323
- King DE, Egan BM, Mainous AG, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens. 2004; 6: 562–568
- Moriel P, Plavnik FL, Zanella MT, Bertolami MC, et al. Lipid peroxidation and antioxidants in hyperlipidemia and hypertension. Biol Res. 2000; 33: 105–112
- Westborg CJ, Eliasson MC, Margareta Eriksson K. A randomized trial of lifestyle intervention in primary healthcare for the modification of cardiovascular risk factors. Scand J Public Health. 2006; 34: 453–461
- Mule G, Cerasola G. The metabolic syndrome and its relationship to hypertensive target organ damage. J Clin Hypertens. 2006; 8: 195–201
- Celik T, Iyisoy A, Kursaklioglu H, Turhan H, et al. Impaired aortic elastic properties in young patients with prehypertension. Blood Press Monit. 2006; 11: 251–255
- Grotto I, Grossman E, Huerta M, Sharabi Y. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. J Hypertens. 2006; 48: 254–259
- Hirofumi T, Tomio A, Yutaka K, Yambe M, et al. The age-related increase in arterial stiffness is augmented in phases according to the severity of hypertension. Hypertens Res. 2004; 27: 465–470
- Greenberg J. Are blood pressure predictors of cardiovascular disease mortality different for prehypertensives than for hypertensives?. Am J Hypertens. 2006; 19: 454–461
- Ulius S, Nesbitt SD, Egan BM, Weber MA, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006; 354: 1685–1697
- Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, et al. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med. 2006; 119: 133–141
- Cohen JD. Managing hypertension: State of the science. J Clin Hypertens. 2006; 8: 5–11